Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy.

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy. Nat Biotechnol. 1998 May; 16(5):444-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.